TransCode Therapeutics, Inc. (RNAZ)
USD 0.41
(1.49%)
USD 0.41
(1.49%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -18.07 Million | -15.76 Million | -5.26 Million | -492.97 Thousand | -508.5 Thousand | -299.57 Thousand |
| Net Income | -18.54 Million | -17.56 Million | -6.84 Million | -2.34 Million | -607.21 Thousand | -453.44 Thousand |
| Depreciation & Amortization | 516.74 Thousand | 98.6 Thousand | 42.47 Thousand | - | - | - |
| Deferred income taxes | 1.29 Billion | 890.95 Thousand | 876.19 Thousand | - | - | - |
| Stock-based compensation | 1.03 Million | 395.32 Thousand | 185.99 Thousand | 45.44 Thousand | 1397.00 | 22.37 Thousand |
| Change in working capital | -1.08 Million | 1.3 Million | 432.38 Thousand | 309.76 Thousand | -4704.00 | 24.94 Thousand |
| Other non-cash items | -1.29 Billion | -890.95 Thousand | 39.47 Thousand | 1.49 Million | 102.01 Thousand | 106.54 Thousand |
| Investing Cash Flow | -35.6 Thousand | -100.91 Thousand | -251.82 Thousand | - | - | - |
| Investments in PPE | -35.6 Thousand | -100.91 Thousand | -254.82 Thousand | - | - | - |
| Acquisitions | - | - | 3000.00 | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -35.6 Million | -100.91 Million | 3.00 | - | - | - |
| Financing Cash Flow | 15.9 Million | 5989.00 | 25.51 Million | 1.11 Million | 500 Thousand | 512.43 Thousand |
| Debt repayment | - | - | - | -1.11 Million | -500 Thousand | -550 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 15.9 Million | 5.98 Million | 26.33 Million | - | - | - |
| Other Financing Activities | 15.9 Thousand | -5.98 Million | -818.55 Thousand | 2.23 Million | 1 Million | -37.56 Thousand |
| Accounts receivables | 360.22 Thousand | -360.22 Thousand | - | - | - | - |
| Accounts payables | -1.29 Million | 1.84 Million | 2.28 Million | 191.25 Thousand | -54.74 Thousand | - |
| Inventory | - | 360.22 Thousand | - | - | - | - |
| Other working capital | -146.27 Thousand | -535.2 Thousand | -1.85 Million | 118.51 Thousand | 50.03 Thousand | 24.94 Thousand |
| Cash at beginning of period | 4.96 Million | 20.82 Million | 828.01 Thousand | 204.47 Thousand | 212.97 Thousand | 120.00 |
| Cash at end of period | 2.76 Million | 4.96 Million | 20.82 Million | 828.01 Thousand | 204.47 Thousand | 212.97 Thousand |
| Capital Expenditure | -35.6 Thousand | -100.91 Thousand | -254.82 Thousand | - | - | - |
| Effect of forex changes on cash | -2.19 Billion | - | - | - | - | - |
| Net cash flow / Change in cash | -2.2 Million | -15.85 Million | 19.99 Million | 623.54 Thousand | -8508.00 | 212.85 Thousand |
| Free Cash Flow | -18.11 Million | -15.86 Million | -5.52 Million | -492.97 Thousand | -508.5 Thousand | -299.57 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.19 Million | -3.32 Million | -4.08 Million | -18.54 Million | -5.29 Million | -4.34 Million |
| Depreciation & Amortization | 142.83 Thousand | 141.64 Thousand | 140.17 Thousand | 516.74 Thousand | 138.78 Thousand | 137.59 Thousand |
| Deferred income taxes | - | - | -2.67 Million | 1.29 Billion | 1.15 Million | -2.05 Million |
| Stock-based compensation | 1143.60 | 183.15 Thousand | 310.31 Thousand | 1.03 Million | 392.33 Thousand | 175.48 Thousand |
| Change in working capital | 1.56 Million | -935.21 Thousand | -2.02 Million | -1.08 Million | 1.26 Million | -363.12 Thousand |
| Other non-cash items | 520.96 Thousand | 1.15 Million | 2.67 Million | -1.29 Billion | -1.15 Million | 2.05 Million |
| Investing Cash Flow | -4555.00 | -3836.00 | -35.57 Million | -35.6 Thousand | -4606.00 | -18.1 Thousand |
| Investments in PPE | -4555.00 | -3836.00 | 35.6 Thousand | -35.6 Thousand | -4606.00 | -18.1 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | -3836.00 | -35.6 Million | -35.6 Million | - | - |
| Financing Cash Flow | 785.19 Thousand | 6.08 Million | 978.15 Thousand | 15.9 Million | 7.39 Million | 6.35 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 785.19 Thousand | 6.08 Million | 978.15 Thousand | 15.9 Million | 7.25 Million | 6.49 Million |
| Other Financing Activities | 785.20 | 6087.14 | 978.15 | 15.9 Thousand | 135.79 Thousand | -135.79 Thousand |
| Accounts receivables | - | - | -360.22 Thousand | 360.22 Thousand | - | - |
| Accounts payables | 908.3 Thousand | -684.49 Thousand | -2.08 Million | -1.29 Million | 1.95 Million | -1.74 Million |
| Inventory | - | - | 360.22 Thousand | - | - | - |
| Other working capital | 656.31 Thousand | -250.72 Thousand | 61.26 Thousand | -146.27 Thousand | -696.05 Thousand | 1.38 Million |
| Cash at beginning of period | 4.91 Million | 2.76 Million | 7.45 Million | 4.96 Million | 3.57 Million | 1.62 Million |
| Cash at end of period | 3.35 Million | 4.91 Million | 2.76 Million | 2.76 Million | 7.45 Million | 3.57 Million |
| Capital Expenditure | -4555.00 | -3836.00 | 35.6 Thousand | -35.6 Thousand | -4606.00 | -18.1 Thousand |
| Effect of forex changes on cash | - | - | - | -2.19 Billion | - | - |
| Net cash flow / Change in cash | -1.55 Million | 2.14 Million | -4.68 Million | -2.2 Million | 3.88 Million | 1.94 Million |
| Free Cash Flow | -2.34 Million | -3.94 Million | -5.62 Million | -18.11 Million | -3.51 Million | -4.4 Million |
QIIK
SADHNANIQ
QC7
300062
INDES
VML